Amber Kaplan, PhD

Dr. Kaplan is an immunologist with experience in innate immunology, infection, cancer and autoimmunity. She brings a wealth of knowledge providing critical input to the development and commercialization of our cellular immunotherapy products.  Most recently, Dr. Kaplan served as Chief Scientific Officer for NKMax America. Prior to NKMax she previously worked in various areas of the biotechnology industry from start-up to venture capital.

Dr. Kaplan earned her PhD in Immunology from Cedars-Sinai Medical Center in Los Angeles, CA and completed her post-doctoral work at the University of California, Los Angeles (UCLA) in the Microbiology, Immunology, and Molecular Genetics Department.